Open AccessDiagnostic and prognostic value of cardiac imaging in amyloidosis
Author(s) -
Rafael Vidal-Pérez,
Raquel Vázquez-García,
Gonzalo BargeCaballero,
Alberto BouzasMosquera,
Rafaela Soler-Fernández,
José M. LarrañagaMoreira,
María G. Crespo–Leiro,
José Manuel VázquezRodríguez
Publication year - 2020
Publication title -
world journal of cardiology
Language(s) - English
Resource type - Journals
ISSN - 1949-8462
DOI - 10.4330/wjc.v12.i12.599
Subject(s) - medicine , cardiac amyloidosis , amyloidosis , value (mathematics) , cardiology , pathology , radiology , machine learning , computer science
Amyloidosis is an infiltrative disease caused by extracellular protein deposition that has accumulated a lot of scientific production in recent years. Different types of amyloidosis can affect the heart. Transthyretin amyloidosis and light chain amyloidosis are the two most common types of cardiac amyloidosis. These entities have a poor prognosis, so accurate diagnostic techniques are imperative for determining an early therapeutic approach. Recent advances in cardiac imaging and diagnostic strategies show that these tools are safe and can avoid the use of invasive diagnostic techniques to histological confirmation, such as endomyocardial biopsy. We performed a review on the diagnostic and prognostic implications of different cardiac imaging techniques in cardiac amyloidosis. We mainly focus on reviewing echocardiography, cardiac magnetic resonance, computed tomography and nuclear imaging techniques and the different safety measurements that can be done with each of them.